The University of Southampton
University of Southampton Institutional Repository

ADHD medication discontinuation and non-adherence: A Norwegian population-based register study

ADHD medication discontinuation and non-adherence: A Norwegian population-based register study
ADHD medication discontinuation and non-adherence: A Norwegian population-based register study

Background: Poor persistence and adherence to attention-deficit/hyperactivity disorder (ADHD) medication is a significant barrier to effective long-term care, particularly during adolescence, yet age-specific and sex-specific trajectories remain poorly characterised. Objective: To characterise medication initiation, discontinuation and long-term adherence patterns for children and adolescents diagnosed with ADHD in a real-world setting. Methods: A nationwide retrospective cohort study, including 8961 children and adolescents (aged <18 years) with a new ADHD diagnosis in child and adolescent mental health services between 1 January 2010 and 31 December 2012, with follow-up until 31 December 2021. Main outcomes were medication initiation rates; time to first medication discontinuation, analysed using Kaplan-Meier estimates and restricted mean survival time at 1 year and longitudinal adherence, measured by the proportion of days covered over 9 years. Findings: Of the 8961 individuals in the cohort (mean age at diagnosis, 12 years; 69% male), 6661 (74.3%) initiated medication, with a median time from diagnosis to initiation of 106 days (IQR 17–231); 55% initiated within 90 days. Discontinuation increased significantly with age; adolescents aged 15–17 years remained on treatment for 31.9 fewer days (95% CI −40.8 to −23.1; p<0.001) in the first year compared with children aged 5–11 years. Females also discontinued significantly earlier than males (difference −13.2 days; 95% CI −19.8 to −6.5; p<0.001). Longitudinal analysis confirmed that older age at initiation and female sex were associated with a significantly steeper decline in medication coverage over time. Conclusions: Discontinuation and low adherence to ADHD medication were common and increased substantially through adolescence, with females at higher risk of early cessation. Clinical implications: Late adolescence warrants closer clinical monitoring and shared decision-making to support appropriate treatment continuation or well-informed discontinuation, particularly for older adolescents and females. Integrating structured transition planning and attention to sex-specific barriers may help reduce avoidable non-adherence during this high-risk period.

Attention Deficit and Disruptive Behavior Disorders, Neurodevelopmental Disorders, Psychopharmacology
2755-9734
Garcia-Argibay, Miguel
e5a6941e-4dcc-401a-9de4-09557c8856ef
Hofstad, Tore
f8981c4b-179e-4344-822a-61f1d2b4e861
Bjelland, Ingvar
b129656e-e8a4-4999-9397-294d585fa03d
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Mykletun, Arnstein
e30319f2-efb1-41db-9f5a-847d567eb170
Garcia-Argibay, Miguel
e5a6941e-4dcc-401a-9de4-09557c8856ef
Hofstad, Tore
f8981c4b-179e-4344-822a-61f1d2b4e861
Bjelland, Ingvar
b129656e-e8a4-4999-9397-294d585fa03d
Cortese, Samuele
53d4bf2c-4e0e-4c77-9385-218350560fdb
Mykletun, Arnstein
e30319f2-efb1-41db-9f5a-847d567eb170

Garcia-Argibay, Miguel, Hofstad, Tore, Bjelland, Ingvar, Cortese, Samuele and Mykletun, Arnstein (2026) ADHD medication discontinuation and non-adherence: A Norwegian population-based register study. BMJ Mental Health, 29 (1), [e302649]. (doi:10.1136/bmjment-2026-302649).

Record type: Article

Abstract

Background: Poor persistence and adherence to attention-deficit/hyperactivity disorder (ADHD) medication is a significant barrier to effective long-term care, particularly during adolescence, yet age-specific and sex-specific trajectories remain poorly characterised. Objective: To characterise medication initiation, discontinuation and long-term adherence patterns for children and adolescents diagnosed with ADHD in a real-world setting. Methods: A nationwide retrospective cohort study, including 8961 children and adolescents (aged <18 years) with a new ADHD diagnosis in child and adolescent mental health services between 1 January 2010 and 31 December 2012, with follow-up until 31 December 2021. Main outcomes were medication initiation rates; time to first medication discontinuation, analysed using Kaplan-Meier estimates and restricted mean survival time at 1 year and longitudinal adherence, measured by the proportion of days covered over 9 years. Findings: Of the 8961 individuals in the cohort (mean age at diagnosis, 12 years; 69% male), 6661 (74.3%) initiated medication, with a median time from diagnosis to initiation of 106 days (IQR 17–231); 55% initiated within 90 days. Discontinuation increased significantly with age; adolescents aged 15–17 years remained on treatment for 31.9 fewer days (95% CI −40.8 to −23.1; p<0.001) in the first year compared with children aged 5–11 years. Females also discontinued significantly earlier than males (difference −13.2 days; 95% CI −19.8 to −6.5; p<0.001). Longitudinal analysis confirmed that older age at initiation and female sex were associated with a significantly steeper decline in medication coverage over time. Conclusions: Discontinuation and low adherence to ADHD medication were common and increased substantially through adolescence, with females at higher risk of early cessation. Clinical implications: Late adolescence warrants closer clinical monitoring and shared decision-making to support appropriate treatment continuation or well-informed discontinuation, particularly for older adolescents and females. Integrating structured transition planning and attention to sex-specific barriers may help reduce avoidable non-adherence during this high-risk period.

Text
Manuscript_clean - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (226kB)

More information

Accepted/In Press date: 3 June 2026
Published date: 22 June 2026
Additional Information: Publisher Copyright: © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
Keywords: Attention Deficit and Disruptive Behavior Disorders, Neurodevelopmental Disorders, Psychopharmacology

Identifiers

Local EPrints ID: 512736
URI: https://eprints.soton.ac.uk/id/eprint/512736
ISSN: 2755-9734
PURE UUID: 1b6de833-bf3e-4211-9640-373c90d01d75
ORCID for Miguel Garcia-Argibay: ORCID iD orcid.org/0000-0002-4811-2330
ORCID for Samuele Cortese: ORCID iD orcid.org/0000-0001-5877-8075

Catalogue record

Date deposited: 22 Jul 2026 16:34
Last modified: 13 Sep 2026 15:49

Export record

Altmetrics

Contributors

Author: Miguel Garcia-Argibay ORCID iD
Author: Tore Hofstad
Author: Ingvar Bjelland
Author: Samuele Cortese ORCID iD
Author: Arnstein Mykletun

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×